ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS

Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorPatel Hospital, Pakistan

About this trial

IN THIS STUDY WOMEN UNDER GOING ELLSCS WOULD BE DIVIDED INTO TWO GROUPS , ONE GROUP WOULD BE GIVEN TRANEXAMIC ACID WHILE THE OTHER WOULD BE GETTING PLACEBO PROPHYLACTICALLY TO SEE THE EFFECT OF TRANEXAMIC ACID IN PREVENTING PPH.

THIS IS A RANDOMIZED CONTROLLED TRIAL. THE SAMPLING TECHNIQUE WOULD BE NON-PROBABILITY TECHNIQUE RANDOMIZATION WOULD BE DONE VIA BALLOTING METHOD.

Eligibility criteria

Qualifiers

Pregnant women with singleton pregnancy and low risk for PPH admitted for ELLSCS

Disqualifiers

Women with history of PPH.

Women with bleeding disorder.

Abnormal placentation (MAP, placenta previa)

Multiple pregnancy.

Trial design

Treatments tested in this trial

  • Tranexamic Acid (TXA)
  • Placebo

Treatment groups

104 Participants
are divided into 2 treatment groups

Sponsors and collaborators